VREOF - Vireo Health International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.5650
+0.0525 (+10.25%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.5125
Open0.5100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4912 - 0.5752
52 Week Range0.2000 - 3.7400
Volume304,975
Avg. Volume128,049
Market Cap48.412M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.7050
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Vireo Health Announces Fourth Quarter and Fiscal Year 2019 Financial Results and Pre-Announces First Quarter 2020 Revenue
      PR Newswire

      Vireo Health Announces Fourth Quarter and Fiscal Year 2019 Financial Results and Pre-Announces First Quarter 2020 Revenue

      Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), the science-focused, multi-state cannabis company with active operations in exclusively medical-only markets and licenses in nine states and the Commonwealth of Puerto Rico, today reported financial results for its fourth quarter and fiscal year ended December 31, 2019. All currency figures referenced in this release reflect U.S. dollar amounts.

    • Vireo Health Announces Update on Timing of Annual Financial Statements and Interim Financial Statements and MD&A
      PR Newswire

      Vireo Health Announces Update on Timing of Annual Financial Statements and Interim Financial Statements and MD&A

      Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in 10 states and the commonwealth of Puerto Rico, today announced the Company will be relying on the general order of the British Columbia Securities Commission (the "BCSC") made under BC Instrument 51-515 entitled "Temporary Exemption from Certain Corporate Finance Requirements" ("BCSC Instrument 51-515"), dated March 23, 2020, to postpone the filing of its annual financial statements and accompanying management's discussion and analysis for the financial year ended December 31, 2019 (together, the "Annual Filings") and the interim financial statements and accompanying management's discussion and analysis for the three months ended March 31, 2020 (together, the "Interim Filings").

    • Vireo Health Announces Formation of Resurgent Biosciences Subsidiary
      PR Newswire

      Vireo Health Announces Formation of Resurgent Biosciences Subsidiary

      Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in nine states and the commonwealth of Puerto Rico, today announced the formation of a wholly-owned subsidiary company called Resurgent Biosciences, Inc. ("Resurgent").

    • Vireo Health Schedules Fourth Quarter and Fiscal Year 2019 Results Conference Call
      PR Newswire

      Vireo Health Schedules Fourth Quarter and Fiscal Year 2019 Results Conference Call

      Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in nine states and the commonwealth of Puerto Rico, today announced an update on the status of the filing of its 2019 fourth quarter and year-end financial results and accompanying management's discussion and analysis for the financial year ended December 31, 2019 (collectively, the "Annual Filings"), which were initially required to be filed by April 29, 2020 under National Instrument 51-102 Continuous Disclosure Obligations.

    • Vireo Health Announces Resignation of Board Member
      PR Newswire

      Vireo Health Announces Resignation of Board Member

      Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in 10 states and the commonwealth of Puerto Rico, today announced that Amy Langer has resigned from the Board of Directors in order to focus on her other business endeavors.

    • Vireo Health Raises $10.5 Million to Increase Sales Volume and Margin
      CNW Group

      Vireo Health Raises $10.5 Million to Increase Sales Volume and Margin

      MINNEAPOLIS , March 10, 2020 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), the science-focused multi-state cannabis company with active operations in exclusively medical-only markets and licenses in 10 states and the commonwealth of Puerto Rico , today announced it has closed the first tranche of a non-brokered private placement offering (the "Offering") of 13,651,574 units of the Company (the "Units"). The Offering was organized by Executive Chairman Bruce Linton and was authorized at a price per Unit of CAD $0.77 for up to a total amount of U.S. $10,000,000 . "This financing reflects the confidence of the capital markets in the potential growth of sales and margin for Vireo," said Executive Chairman, Bruce Linton .

    • Vireo Health Expands Partnership with Leaf Trade
      PR Newswire

      Vireo Health Expands Partnership with Leaf Trade

      Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced the expansion of the Company's partnership with Leaf Trade to provide a wholesale order and fulfillment management platform in four states where Vireo operates. Leaf Trade is an omni-channel sales platform that allows Vireo's wholesale business to come online quickly and easily in new markets as the Company expands its operations nationally.

    • GlobeNewswire

      CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial

      CB2 chosen to advance application with the US FDA for study on safety and efficacy of cannabis-based topical treatments by leading multistate operator, Vireo. Project marks the start of the clinical trial process for Vireo’s topical creams, lotions and gels to be used by patients for pain management. Company will develop full protocols and manage Investigational New Drug (IND) application on behalf of Vireo and will work with the FDA towards approvals.

    • Vireo Health Employees Ratify First Cannabis Union Contract in Maryland History with UFCW Local 27
      PR Newswire

      Vireo Health Employees Ratify First Cannabis Union Contract in Maryland History with UFCW Local 27

      United Food and Commercial Workers Local 27 (UFCW27) and Vireo Health International, Inc. ("Vireo" or "the Company") (CNSX: VREO; OTCQX: VREOF), today announced that workers at its wholly-owned subsidiary, MaryMed, LLC ("MaryMed"), voted overwhelmingly to ratify a Collective Bargaining Agreement and officially join the ranks of UFCW Local 27.

    • Vireo Health Launches Lower-THC 'LiteBud' Brand
      PR Newswire

      Vireo Health Launches Lower-THC 'LiteBud' Brand

      Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced the launch of LiteBud, a patent-pending line of consistently formulated, lower-Tetrahydrocannabinol (THC) cannabis products that are designed to meet the needs of cannabis consumers seeking a more consistent, controlled and mild experience.

    • Vireo Health CEO and Founder Kyle Kingsley, M.D. Signs CEO Action for Diversity & Inclusion™ Pledge
      PR Newswire

      Vireo Health CEO and Founder Kyle Kingsley, M.D. Signs CEO Action for Diversity & Inclusion™ Pledge

      Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-founded, science-focused multi-state cannabis company today announced that the Company's CEO and Founder Kyle Kingsley, M.D. has signed the CEO Action for Diversity & Inclusion™ Pledge.

    • Vireo Health to Report Third Quarter 2019 Results on November 27, 2019
      PR Newswire

      Vireo Health to Report Third Quarter 2019 Results on November 27, 2019

      MINNEAPOLIS , Nov. 18, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, ...

    • Vireo Health Names Shaun Nugent Chief Financial Officer
      PR Newswire

      Vireo Health Names Shaun Nugent Chief Financial Officer

      Nugent Brings 25 Years of Financial Experience Having Previously Served as CFO at Life Time Fitness, Champps Entertainment, and Sun Country Airlines MINNEAPOLIS , Nov. 14, 2019 /PRNewswire/ -- Vireo Health ...

    • Vireo Health Appoints Amber Shimpa to the New Role of Chief Administrative Officer
      PR Newswire

      Vireo Health Appoints Amber Shimpa to the New Role of Chief Administrative Officer

      MINNEAPOLIS, Nov. 13, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), the leading science-focused multi-state cannabis company, today announced that Amber Shimpa will be transitioning to the newly created role of Chief Administrative Officer ("CAO") on December 2, 2019. As CAO, Ms. Shimpa will continue to lead the Company's human resources and business administration teams and further drive the integration of people and culture for Vireo.

    • Former Canopy Growth CEO Bruce Linton joins US cannabis company's board, Vireo stock surges 35%
      Yahoo Finance

      Former Canopy Growth CEO Bruce Linton joins US cannabis company's board, Vireo stock surges 35%

      After parting ways with Canadian cannabis giant Canopy Growth, Bruce Linton is joining the board of U.S. multi-state operator Vireo Health.

    • Vireo Health Names Bruce Linton as Executive Chairman
      PR Newswire

      Vireo Health Names Bruce Linton as Executive Chairman

      MINNEAPOLIS, Nov. 7, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced that it has named Bruce Linton to the role of Executive Chairman. As Executive Chairman, Mr. Linton will be actively involved in the Company's business.

    • Market Exclusive

      Cannabis Stock News Roundup October 31

      Aurora Cannabis (NYSE: ACB) (TSX: ACB) announced the launch of Ready for Edibles, a national bilingual campaign to educate new and experienced cannabis consumers on responsible consumption and safe storage of edibles products before they become available for sale in December. Core One Labs (CSE: COOL) (OTCQX: CLABF) (Frankfurt: LD6) announced that its board of directors […]The post Cannabis Stock News Roundup October 31 appeared first on Market Exclusive.

    • Vireo Health Launches New 'Green Goods' Retail Dispensary Brand in Scranton, Pennsylvania
      PR Newswire

      Vireo Health Launches New 'Green Goods' Retail Dispensary Brand in Scranton, Pennsylvania

      MINNEAPOLIS , Oct. 30, 2019 /PRNewswire/ -- Vireo Health International, Inc., ("Vireo" or the "Company") (CSNX: VREO; OTQX: VREOF), a leading physician-founded, science-focused multi-state ...

    • Benzinga

      Vireo Health Offers Dry Flower To Pennsylvania, Maryland Dispensaries With New 1937 Brand

      1937 also represents the company’s first foray into offering dry flower. The brand, named after the Marihuana Tax Act of 1937 which prohibited cannabis in the United States, plans to release a line of concentrates later in the year. Products can be found in dispensaries in Maryland and Pennsylvania.

    • Vireo Health Launches 1937 Cannabis Brand
      PR Newswire

      Vireo Health Launches 1937 Cannabis Brand

      1937 Cannabis features historic cannabis strains and will be available in both dry flower and concentrates MINNEAPOLIS , Oct. 17, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" ...

    • Vireo Health Names Ari Hoffnung Chief Strategy Officer
      PR Newswire

      Vireo Health Names Ari Hoffnung Chief Strategy Officer

      MINNEAPOLIS , Oct. 14, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-founded, science-focused multi-state ...

    • PR Newswire

      Vireo Health Employees Ratify First Cannabis Union Contract in Pennsylvania with UFCW 1776KS

      PHILADELPHIA , Oct. 7, 2019 /PRNewswire/ -- United Food and Commercial Workers Local 1776 Keystone State and Vireo Health International, Inc. ("Vireo") (CNSX: VREO; OTCQX: VREOF), announced that ...

    • Vireo Health to Present at the Canaccord Genuity U.S. Cannabis Symposium
      PR Newswire

      Vireo Health to Present at the Canaccord Genuity U.S. Cannabis Symposium

      MINNEAPOLIS , Oct. 2, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state ...

    • Market Exclusive

      Cannabis Stock News Daily Roundup September 23

      TerrAscend (CSE: TER) (OTCQX: TRSSF) has closed the acquisition of Ilera Healthcare, a permitted cannabis cultivator, processor, and dispensary operators in Pennsylvania. This acquisition expands the company's licensed cannabis footprint to four U.S. states, in addition to its global reach into Canada and Europe. Hemp Technology (OTCPK: CPOW) has signed an agreement to purchase Pettanicals Pet Treats, a […]The post Cannabis Stock News Daily Roundup September 23 appeared first on Market Exclusive.

    • Vireo Health Announces DTC Eligibility for Publicly Traded Shares
      PR Newswire

      Vireo Health Announces DTC Eligibility for Publicly Traded Shares

      MINNEAPOLIS , Sept. 19, 2019 /PRNewswire/ --   Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis ...